Mangrove Partners’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,416
Closed -$186K 185
2024
Q3
$186K Buy
+21,416
New +$186K 0.02% 140